Mineralys Therapeutics In...

NASDAQ: MLYS · Real-Time Price · USD
14.46
-0.88 (-5.74%)
At close: Aug 19, 2025, 3:59 PM
14.47
0.07%
After-hours: Aug 19, 2025, 05:13 PM EDT

Mineralys Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-177.81M -71.9M -29.8M -19.41M
Depreciation & Amortization
43K n/a n/a n/a
Stock-Based Compensation
11.34M 5.06M 455K 80K
Other Working Capital
9.1M -7.47M 772K 4.08M
Other Non-Cash Items
-9.4M -6.87M -649K 684K
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
9.52M -7.47M 772K 4.08M
Operating Cash Flow
-166.31M -81.17M -29.22M -14.56M
Capital Expenditures
-96K n/a n/a n/a
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
-373.44M -347.97M -71.76M n/a
Sales Maturities Of Investments
488.5M 187.5M 50M n/a
Other Investing Acitivies
n/a n/a n/a n/a
Investing Cash Flow
114.96M -160.47M -21.76M n/a
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a -1.63M n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
83K 258K n/a n/a
Financial Cash Flow
116.14M 203.25M 128.02M 23.81M
Net Cash Flow
64.79M -38.4M 77.04M 9.25M
Free Cash Flow
-166.41M -81.17M -29.22M -14.56M